Abstract
The 2018 WHO position paper on typhoid vaccines indicates preference for the use of new generation typhoid conjugate vaccines over existing parenteral Vi-polysaccharide (Vi-PS) and oral attenuated Ty21a vaccines
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Humans
-
Mass Vaccination / statistics & numerical data*
-
Travel*
-
Typhoid Fever / prevention & control*
-
Typhoid-Paratyphoid Vaccines / administration & dosage*
-
Typhoid-Paratyphoid Vaccines / immunology
-
Vaccines, Conjugate / immunology
Substances
-
Typhoid-Paratyphoid Vaccines
-
Vaccines, Conjugate